Whole tumor MR Perfusion histogram analysis in the preoperative assessment of patients with gliomas: Differentiation between high- and low-grade tumors
暂无分享,去创建一个
Kostas Marias | Katerina Nikiforaki | George Kyriakopoulos | Vasileios K. Katsaros | George Stranjalis | Nikolaos Papanikolaou | E. Liouta | G. Stranjalis | G. Kyriakopoulos | K. Marias | V. Katsaros | N. Papanikolaou | Giorgos Manikis | Evangelia Liouta | Christos Boskos | K. Nikiforaki | Giorgos Manikis | C. Boskos
[1] R R Edelman,et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. , 1990, Radiology.
[2] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[3] C Tanaka,et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. , 1996, Magnetic resonance imaging.
[4] B R Rosen,et al. Clinical applications of intracranial perfusion MR imaging. , 1999, Neuroimaging clinics of North America.
[5] G Johnson,et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.
[6] V. Jellús,et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. , 2001, AJNR. American journal of neuroradiology.
[7] M. Kitajima,et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI , 2002, Neuroradiology.
[8] Glyn Johnson,et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.
[9] Glyn Johnson,et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.
[10] Michael H Lev,et al. Dynamic magnetic resonance perfusion imaging of brain tumors. , 2004, The oncologist.
[11] Michael H Lev,et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. , 2004, AJNR. American journal of neuroradiology.
[12] J. Guyotat,et al. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors , 2006, Neuroradiology.
[13] I. Ercan,et al. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. , 2005, Clinical radiology.
[14] R M Weisskoff,et al. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. , 2006, AJNR. American journal of neuroradiology.
[15] Glyn Johnson,et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. , 2006, Radiology.
[16] S. Y. Kim,et al. A Prospective Study on the Added Value of Pulsed Arterial Spin-Labeling and Apparent Diffusion Coefficients in the Grading of Gliomas , 2007, American Journal of Neuroradiology.
[17] Mitchel S Berger,et al. Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. , 2007, Journal of neurosurgery.
[18] P. Baraldi,et al. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging , 2007, Neuroradiology.
[19] Elias R Melhem,et al. Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience. , 2007, Radiology.
[20] A. Bjørnerud,et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. , 2008, Radiology.
[21] R. Agid,et al. Preoperative Grading of Presumptive Low-Grade Astrocytomas on MR Imaging: Diagnostic Value of Minimum Apparent Diffusion Coefficient , 2008, American Journal of Neuroradiology.
[22] A. Bjørnerud,et al. Histogram Analysis of MR Imaging–Derived Cerebral Blood Volume Maps: Combined Glioma Grading and Identification of Low-Grade Oligodendroglial Subtypes , 2008, American Journal of Neuroradiology.
[23] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[24] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[25] Soonmee Cha,et al. Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy. , 2014, CNS oncology.